[HTML][HTML] Recent advances in long-acting drug delivery systems for anticancer drug

C Pacheco, A Baiao, T Ding, W Cui… - Advanced Drug Delivery …, 2023 - Elsevier
The use of systemic anticancer chemotherapy is intrinsically limited by its toxicity. Whether
dealing with small molecules or biopharmaceuticals, after systemic administration, small …

Chitosan-and hyaluronic acid-based nanoarchitectures in phototherapy: combination cancer chemotherapy, immunotherapy and gene therapy

Z Wang, S Pang, X Liu, Z Dong, Y Tian… - International Journal of …, 2024 - Elsevier
Cancer phototherapy has introduced a new potential modality for tumor suppression.
However, the efficacy of phototherapy has been limited due to a lack of targeted delivery of …

[HTML][HTML] Chitosan-functionalized bioplatforms and hydrogels in breast cancer: immunotherapy, phototherapy and clinical perspectives

T Li, M Ashrafizadeh, Y Shang, YN Ertas, G Orive - Drug Discovery Today, 2024 - Elsevier
Highlights•Breast cancer is a leading cause of death among women.•Chitosan is a
biodegradable and biocompatible polymer obtained from chitin.•Chitosan-based …

Nano-formulations for transdermal drug delivery: A review

X Zhou, Y Hao, L Yuan, S Pradhan, K Shrestha… - Chinese Chemical …, 2018 - Elsevier
Transdermal drug delivery refers to a means of delivering drugs through the surface of the
skin for local or systemic treatment. The drug functions after absorption through the skin into …

Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review

CS Kue, SY Ng, SH Voon, A Kamkaew… - Photochemical & …, 2018 - Springer
BODIPYs are photosensitizers activatable by light to generate highly reactive singlet oxygen
(1 O 2) from molecular oxygen, leading to tissue damage in the photoirradiated region …

pH-responsive chitosan-adorned niosome nanocarriers for co-delivery of drugs for breast cancer therapy

S Karimifard, N Rezaei, E Jamshidifar… - ACS Applied Nano …, 2022 - ACS Publications
Breast cancer incidence has increased in recent decades. In the present study, an optimum
formulation of chitosan (CS)-adorned niosome-based nanocarriers for co-delivery of …

PLGA's plight and the role of stealth surface modification strategies in its use for intravenous particulate drug delivery

VV Sheffey, EB Siew, EEL Tanner… - Advanced …, 2022 - Wiley Online Library
Numerous human disorders can benefit from targeted, intravenous (IV) drug delivery.
Polymeric nanoparticles have been designed to undergo systemic circulation and deliver …

[HTML][HTML] Multi-stimuli-responsive chitosan-functionalized magnetite/poly (ε-caprolactone) nanoparticles as theranostic platforms for combined tumor magnetic …

G García-García, C Caro, F Fernández-Álvarez… - … , Biology and Medicine, 2023 - Elsevier
Chitosan-functionalized magnetite/poly (ε-caprolactone) nanoparticles were formulated by
interfacial polymer disposition plus coacervation, and loaded with gemcitabine. That …

Antibiotic and inorganic nanoparticles co-loaded into carboxymethyl chitosan-functionalized niosome: Synergistic enhanced antibacterial and anti-biofilm activities

S Ashkezari, MS Abtahi, Z Sattari, MT Yaraki… - Journal of Drug Delivery …, 2023 - Elsevier
Niosomes are biocompatible nanocarriers that could be used for designing drug delivery
systems. In this work, we report the synthesis, characterization and antibacterial/antibiofilm …

Chitosan-based drug delivery systems for optimization of photodynamic therapy: A review

GMF Calixto, SR de Annunzio, FD Victorelli… - Aaps Pharmscitech, 2019 - Springer
Drug delivery systems (DDS) can be designed to enrich the pharmacological and
therapeutic properties of several drugs. Many of the initial obstacles that impeded the clinical …